GlassScriptPhysician profile
Anna Pancheshnikov
NPI 1750739686
$8,479.79
in general payments reported to CMS, 2019-2025
6 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $191 · 2023: $5,444 · 2024: $2,684 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,000 · Travel and Lodging: $2,726 · Education: $2,000 · Food and Beverage: $563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,000.00 |
| Travel and Lodging | $2,726.27 |
| Education | $2,000.00 |
| Food and Beverage | $562.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,703.88 | 2023-2025 | Davinci Xi, Da Vinci Surgical System |
| Caldera Medical, INC | $3,000.00 | 2023 | Desara |
| Medtronic, INC. | $1,356.83 | 2023-2025 | Interstim |
| Boston Scientific Corporation | $364.25 | 2022-2024 | Solyx Sis System, Upsylon, Advantage System |
| Baxter Healthcare | $33.89 | 2023 | Tisseel |
| Valencia Technologies Corporation | $20.94 | 2023 | Ecoin Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Pancheshnikov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.